LACRIFILL^® Canalicular Gel by Nordic Pharma, Inc.

LACRIFILL^®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Neel R. Desai, MD

Show Description +

Neel Desai, MD, hosts this on-demand webinar on LACRIFILL^® Canalicular Gel (Nordic Pharma, Inc.) and its proven effectiveness as a treatment for dry eye disease. Attendees learned more about this cross-linked hyaluronic acid, the administration procedure, clinical trial data, and important reimbursement information.

Posted: 9/06/2024

Keywords:

LACRIFILL^® Educational Series

Up Next

Exploring the Launch of LACRIFILL® Canalicular Gel

Jai G. Parekh, MD, MBA, FAAO; Darrell E. White, MD; and Phil Gioia

Administration of LACRIFILL^®

Administering LACRIFILL<sup>®</sup> Canalicular Gel as an In-Office Procedure

Administering LACRIFILL^® Canalicular Gel as an In-Office Procedure

Brandon D. Ayres, MD

LACRIFILL^® Educational Series

LACRIFILL<sup>®</sup>: Dry Eye Treatment Webinar with Dr Darrell White, MD

LACRIFILL^®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Darrell E. White, MD

LACRIFILL^®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Neel R. Desai, MD

Overview of LACRIFILL^®

LACRIFILL<sup>®</sup> Canalicular Gel: The Future of Dry Eye Treatment

LACRIFILL^® Canalicular Gel: The Future of Dry Eye Treatment

John P. Fezza, MD

Back to All Videos

LACRIFILL^®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Neel R. Desai, MD

Neel Desai, MD, hosts this on-demand webinar on LACRIFILL^® Canalicular Gel (Nordic Pharma, Inc.) and its proven effectiveness as a treatment for dry eye disease. Attendees learned more about this cross-linked hyaluronic acid, the administration procedure, clinical trial data, and important reimbursement information.

Posted: 9/06/2024

Keywords:

LACRIFILL^® Educational Series

Resources

LACRIFILL<sup>®</sup> and Reimbursement image

LACRIFILL^® and Reimbursement

View Resource

LACRIFILL<sup>®</sup> Instructions for Use image

LACRIFILL^® Instructions for Use

View Resource

LACRIFILL^® Canalicular Gel Detail Aid

View Resource

About Nordic Pharma

Nordic Pharma, Inc., subsidiary of Nordic Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.

Visit us online: nordicpharmausa.com

Request a Brochure | Contact Us

Dr. Brandon Ayres, Kevin Corcoran, Dr. Neel Desai, and Dr. John Fezza are paid consultants of Nordic Pharma, Inc.

Contraindications
LACRIFILL is contraindicated for patients experiencing epiphora, inflammation of the eye lid, and tearing secondary to dacryocystitis with mucopurulent discharge and any other active ocular or periocular infection, those who are allergic to hyaluronic acid or to the specific device material, and those who have known lacrimal outflow obstruction.

Rx Only

The Nordic Pharma Logo is a trademark of Nordic Group B.V.

Nordic Pharma, Inc. / 1205 Westlakes Dr., Suite 275, Berwyn, PA 19312

062024309 • PM24-010-2V5

LACRIFILL^® is a registered trademark of Nordic Pharma, Inc.

U.S. Pat. Nos. 8,979,821 and 9,504,605.

LACRIFILL®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Up Next

Administration of LACRIFILL®

LACRIFILL® Educational Series

Overview of LACRIFILL®

LACRIFILL®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Resources

LACRIFILL^®: Dry Eye Treatment Webinar with Dr Darrell White, MD

Administration of LACRIFILL^®

LACRIFILL^® Educational Series

Overview of LACRIFILL^®

LACRIFILL^®: Dry Eye Treatment Webinar with Dr Darrell White, MD